Patent 7465798 was granted and assigned to Wyeth on December, 2008 by the United States Patent and Trademark Office.
The present invention relates to the field of anti-inflammatory substances, and more particularly to novel compounds that act as antagonists of the mammalian adhesion proteins known as selectins. In some embodiments, methods for treating selectin mediated disorders are provided which include administration of compound of Formula I: